Be careful with the GLP-1s agonists e.g. Pfizer now ends its clinical trial an of oral GLP-1 drug called danuglipron. The statement suggests that the patient’s liver enzymes were elevated which often

Substack vax - Trending on BuzzSumo 2025-04-14

Summary:

Be careful with the GLP-1s agonists e.g. Pfizer now ends its clinical trial an of oral GLP-1 drug called danuglipron. The statement suggests that the patient’s liver enzymes were elevated which often substack.com

Link:

https://palexander.substack.com/p/be-careful-with-the-glp-1s-agonists

From feeds:

Authors:

Dr. Paul Alexander

Date tagged:

04/14/2025, 14:40

Date published:

04/14/2025, 11:34